Table 1.
Characteristics of the patients elected for chest drainage.
| Sex (M/F), n | 24/40 |
| Age (years) | 61.4 (39‐87) |
| Affected side (R/L/B), n | 34/28/2 |
| Time from diagnosis until pleurodesis (months) | 2 (1‐13) |
| Previous Thoracenthesis(n)* | 3 (1‐7) |
| Primary Site (n) | |
| Breast | 27 |
| Lung | 22 |
| Undetermined | 7 |
| Kidney | 3 |
| Others** | 5 |
| Oncological Treatment (n) | |
| Thoracic radiotherapy | 14 |
| Chemotherapy (ongoing) | 20 |
| None | 25 |
| Pleural Fluid Characteristics | |
| Oncotic cytology (pos/neg) | 34/10 |
| pH | 7.2 (6.8‐7.7) |
| Glucose (mg/dL) | 88 (11‐190) |
| Protein (g/dL) | 4.3 (1.7‐6.2) |
| DHL (U/L) | 709 (92‐6194) |
| ADA (U/L) | 22.1 (9.7‐113.6) |
Thoracentesis*: Number of thoracentesis prior to pleurodesis
Others**: Lymphoma, ovarian carcinoma, laryngeal carcinoma.
Results are expressed as median (+range)